We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
BETAVANT (Nova Pharmaceuticals Australasia Pty Ltd)
Product name
BETAVANT
Date registered
Evaluation commenced
Decision date
Approval time
141 (255 working days)
Active ingredients
betamethasone dipropionate
Registration type
New generic medicine
Indication
TRADENAME is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. These include atopic eczema, infantile eczema, nummular eczema, contact dermatitis, neurodermatitis, anogenital and senile pruritus, lichen planus, intertrigo and psoriasis.